home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences  

4th Annual Formulation & Drug Delivery Congress

  January 05, 2018  
Oxford Global Conferences, London

Join Oxford Global’s 4th Annual Formulation & Drug Delivery Congress, 8 – 9 May 2018 in London. A new feature of the revamped 2018 agenda is the expansion of the programme to cover advanced drug delivery devices and the areas of bioanalysis & stabilisation. Leading experts will discuss slow delivery devices for antibodies, needle-free delivery systems as well as updates in auto-injectors. The bioanalysis & stabilisation session will look at such areas as bioanalytical development for large molecules, prediction and characterisation of aggregates and particle-size analysis.

Over 350 senior level experts will be attending the 2018 event to network about the latest developments & participate in presentations covering the below main areas: 

·         Large Molecule Drug Formulation

·         Advances in Drug Delivery

·         New to 2018! Drug Delivery Devices

·         Small Molecule Drug Formulation

·         New to 2018! Bioanalysis and Stabilisation

View Agenda:  http://bit.ly/2zFQHzn


Large Molecule Formulation & Drug Delivery
Hosted by Paresh N. Vadgama, Principal Scientist, Glenmark Pharmaceuticals
Register for Free Now:

Nano-based Oncological Drug Delivery
Hosted by Marianne Ashford, Principal Scientist, Drug Targeting, AstraZeneca
& Constantin-C. Coussios, Statutory Chair of Biomedical Engineering, University of Oxford
Register for Free Now:

Novel Oral Formulation & Drug Delivery
Hosted by Margaret Landis, Associate Research Fellow, Pfizer
& Dennis Douroumis, Director of Centre for Innovation in Process Engineering and Research, University of Greenwich
Register for Free Now:

Organized by: OxfordGlobal
Invited Speakers:

2018 Formulation & Drug Delivery Congress Confirmed Speakers Include:

Menashe Levy, Chief Technology Officer and Vice President, Global R&D
Teva Pharmaceuticals

Mano Manoharan, Senior Vice President Innovation Chemistry
Alnylam Pharmaceuticals

Svend Ludvigsen, Senior Scientific Director
Novo Nordisk

Advait Badkar, Senior Director

Jens Sydor, Director, Global DMPK Development Support & Bioanalysis

René Holm, Head and Scientific Director, Liquids & Parenterals
The Janssen Pharmaceutical Companies of Johnson & Johnson

Bernardo Perez-Ramirez, Senior Scientific Director, Global Pharmaceutics Development Biologics

Sushma Kommareddy, Associate Director, Formulation Development
Alnylam Pharmaceuticals

Marc Du Jardin, Regional Head Pharmaceutical Developability (Beerse)
Takeda Pharmaceuticals

Giustino Di Pretoro, Associate Director
Janssen Research & Development, PDMS

Florence Arvis, Head of Formulation Unit

Jérôme Mantanus, Head of Formulation & Process Characterization

Riccardo Torosantucci, Head, Formulation Development

Thorsten Lorenz, Head Developability Assessment
Novartis Pharma AG

Margaret Landis, Associate Research Fellow

Sreedhara Alavattam, Senior Group Leader and Principal Scientist

Lennart Lindfors, Principal Scientist

Aditya Tatavarti, Principal Scientist

Aktham Aburub, Senior Research Advisor
Eli Lilly and Company

Axel Becker, Senior Scientist
Merck KGaA

Duncan Craig, Professor of Drug Delivery and Director
University College London

Karsten Mäder, Full Professor and Head of the Pharmaceutics and Biopharmaceutics
Martin-Luther-University Halle

Amir Tamiz, Programme Director

Constantin-C. Coussios, Statutory Chair of BiomedicalEngineering
University of Oxford


2018 Co-located Inhalation & Respiratory Drug Delivery Congress Confirmed Speakers Include: 

Alison Moore, Clinical Development Director

Prasad Peri, Senior Director Regulatory Affairs, Respiratory & Devices

Holger Memmesheimer, Head of Quality Chemical Production (Former Head of Respiratory Drug Delivery)
Boehringer Ingelheim 

Mikael Brulls, Associate Principal Scientist

Darragh Murnane, Professor, Pharmacy & Pharmacology
University of Hertfordshire

Ben Forbes, Professor
King’s College London

Robert Price, Professor in Pharmaceutics
University of Bath

Nicolas Roche, Professor of Respiratory Medicine
University Paris Descartes

Leslie Yeo, Professor & Australian Research Council Future Fellow
RMIT University

Richard Costello, Associate Professor, Medicine
Royal College of Surgeons in Ireland

Carsten Ehrhardt, Associate Professor, Pharmacy
Trinity College Dublin

Josué Sznitman, Associate Professor, Biomedical Engineering
Israel Institute of Technology

Sandro da Rocha, Associate Professor Chemical and Life Science Engineering
King’s College London

Paul Royall, Senior Lecturer in Pharmaceutics
King’s College London

Federico Lavorini, senior Physician
University of Florence

Francesca Buttini, Assistant Professor
University of Parma

Imran Saleem, Reader, School of Pharmacy & Biomolecular Sciences
Liverpool John Moores University

Allen Haddrell, Senior Research Fellow
University of Bristol

Deadline for Abstracts: 2018-05-08


E-mail: g.alonso@oxfordglobal.co.uk
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.